OPTIMIZERx Corp
NASDAQ:OPRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G-Tec Jainx Education Ltd
NSE:GTECJAINX
|
IN |
|
Bexil Corp
OTC:BXLC
|
US |
|
T
|
True Games Syndicate SA
WSE:TGS
|
PL |
|
Fleury SA
BOVESPA:FLRY3
|
BR |
|
C
|
Continental Petroleums Ltd
BSE:523232
|
IN |
|
M
|
Mama's Creations Inc
NASDAQ:MAMA
|
US |
|
Vault Minerals Ltd
ASX:VAU
|
AU |
|
Industrials REIT Ltd
LSE:MLI
|
UK |
|
I
|
Innovation Beverage Group Ltd
NASDAQ:IBG
|
AU |
|
Whirlpool SA
BOVESPA:WHRL4
|
BR |
|
Bilendi SA
PAR:ALBLD
|
FR |
OPTIMIZERx Corp
Research & Development
OPTIMIZERx Corp
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
OPTIMIZERx Corp
NASDAQ:OPRX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Research & Development
-$767.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-28%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Research & Development
-$103.2m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Research & Development
-$93m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Research & Development
-$87.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Research & Development
-$54.6m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
OPTIMIZERx Corp
Glance View
OptimizeRx Corp. is digital health company, engaging in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Rochester, Michigan and currently employs 97 full-time employees. The company went IPO on 2005-05-18. The firm enables engagement between life sciences organizations, healthcare providers and patients. The company connects approximately 60% of United States healthcare providers and their patients through a technology platform embedded within its own point-of-care network. The firm principal solutions and applications include financial messaging, brand therapeutic support messaging, and brand support. Its financial messaging enables doctors and staffs to access a universe of sample voucher, co-pay coupons and other patient support option through their electronic medical records (EMR) and/or e-prescribe system. Its brand messaging service includes brands awareness message, reminder advertisement, therapeutic support and unbranded messages. Its brand support is focused on educating and working with pharmaceuticals manufacturer on identifying, formulation and implementing new eRx media strategy for promoting their solutions.
